Cancer Causes & Control

, Volume 17, Issue 4, pp 531–537 | Cite as

Risk of Breast Cancer After Night- and Shift Work: Current Evidence and Ongoing Studies in Denmark

Special Section on Cancer and Rhythm Original Paper


Breast cancer is the most frequent cancer among women, and the number is increasing worldwide. This tumour is strongly associated with Western lifestyle, but the specific risk factors behind this observation are not well known. Exposure to light-at-night, including disturbance of the circadian rhythm, possibly mediated via the melatonin synthesis and clock genes, has been suggested as a contributing cause of breast cancer. Since shift- and night-time work is prevalent and increasing in modern societies, this exposure may be of public health concern, and contribute to the continuing elevation in breast cancer risk. Until now only few epidemiological studies have evaluated breast cancer risk after shift- and night- work. Although these studies are all suffering from methodological problems, especially concerning assessment of light exposure, results have consistently shown an increase in risk associated with night- and shift work. Good opportunities for epidemiological cancer research exist in Denmark, and several studies on different aspects of breast cancer, work schedules, light exposure and melatonin levels are ongoing in order to further examine different aspects of this issue.


Breast cancer Occupational exposure Light at night Circadian rhythm Melatonin 


  1. 1.
    Parkin DM (2004) International variation. Oncogene 23:6329–6340CrossRefPubMedGoogle Scholar
  2. 2.
    Chia KS, Reilly M, Tan CS, etal. (2004) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113(2):1041–1047Google Scholar
  3. 3.
    Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133–140CrossRefPubMedGoogle Scholar
  4. 4.
    Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213–218CrossRefPubMedGoogle Scholar
  5. 5.
    Hung HC, Joshipura KJ, Jiang R, etal. (2004) Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96:1577–1584PubMedGoogle Scholar
  6. 6.
    Russo J, Hasan LM, Balogh G, Guo S, Russo IH (2003) Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87:1–25CrossRefPubMedGoogle Scholar
  7. 7.
    Blair A, Rothman N, Zahm SH (1999) Occupational cancer epidemiology in the coming decades. Scand J Work Environ Health 25:491–497PubMedGoogle Scholar
  8. 8.
    Blair A, Zahm SH, Silverman DT (1999) Occupational cancer among women: research status and methodologic considerations. Am J Ind Med 36:6–17CrossRefPubMedGoogle Scholar
  9. 9.
    Welp EA, Weiderpass E, Boffetta P, etal. (1998) Environmental risk factors of breast cancer. Scand J Work Environ Health 24:3–7PubMedGoogle Scholar
  10. 10.
    Goldberg MS, Labreche F (1996) Occupational risk factors for female breast cancer: a review.Occup Environ Med 53:145–156PubMedGoogle Scholar
  11. 11.
    Labreche FP, Goldberg MS (1997) Exposure to organic solvents and breast cancer in women: a hypothesis. Am J Ind Med 32:1–14PubMedGoogle Scholar
  12. 12.
    Peplonska B, Szeszenia-Dabrowska N (2001) Occupational risk factors for breast cancer in the epidemiological studies. Med Pr 52:483–495PubMedGoogle Scholar
  13. 13.
    Caplan LS, Schoenfeld ER, O’Leary ES, Leske MC (2000) Breast cancer and electromagnetic fields–a review. Ann Epidemiol 10:31–44PubMedGoogle Scholar
  14. 14.
    Band PR, Le ND, Fang R, Deschamps M, Gallagher RP, Yang P (2000) Identification of occupational cancer risks in British Columbia. A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med 42:284–310PubMedGoogle Scholar
  15. 15.
    Rajarantnam SMW, Arendt J (2001). Health in a 24-h society. The Lancet 358:999–1005Google Scholar
  16. 16.
    Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125:556–561PubMedGoogle Scholar
  17. 17.
    Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW (1992) Electric power, pineal function, and the risk of breast cancer. FASEB J 6:853–860PubMedGoogle Scholar
  18. 18.
    Stevens RG (1993) Breast cancer and electric power. Biomed Pharmacother 47:435–458CrossRefPubMedGoogle Scholar
  19. 19.
    Stevens RG, Davis S (1996) The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 104 (Suppl 1):135–140PubMedGoogle Scholar
  20. 20.
    Stevens RG, Rea MS (2001) Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12:279–287CrossRefPubMedGoogle Scholar
  21. 21.
    Brzezinski A (1997) Melatonin in humans. N Engl J Med 336:186–195CrossRefPubMedGoogle Scholar
  22. 22.
    Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C (2000) Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 526(Pt3): 695–702PubMedGoogle Scholar
  23. 23.
    Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B (1981) Melatonin inhibition and pinealectomy enchancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 41:4432–4436PubMedGoogle Scholar
  24. 24.
    Blask DE, Pelletier DB, Hill SM, etal. (1991) Pineal melatonin inhibition of tumor promotion in the N-nitroso- N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 117:526–532CrossRefPubMedGoogle Scholar
  25. 25.
    Anisimov VN (2002) The light-dark regimen and cancer development. Neuro Endocrinol Lett 23(Suppl 2):28–36PubMedGoogle Scholar
  26. 26.
    Blask DE, Wilson ST, Zalatan F (1997) Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Cancer Res 57:1909–1914PubMedGoogle Scholar
  27. 27.
    van den Heiligen S, Depres-Brummer P, Barbason H, Claustrat B, Reynes M, Levi F (1999) The Tumor promoting effect of constant light exposure on diethylamine-induced hepatocarcinogenesis in rats. Life Sci 64:2523–2534Google Scholar
  28. 28.
    Baldwin WS, Barrett JC (1998) Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers. Mol Carcinog 21:149–155CrossRefPubMedGoogle Scholar
  29. 29.
    Stevens RG, Rea MS (2001) Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12:279–287CrossRefPubMedGoogle Scholar
  30. 30.
    Mediavilla MD, Cos S, Sanchez-Barceolo EJ (2001) Melatonin increases p53 and p21WAF1 expression in MCF–7 human breast cells in vitro. Life Sci 65:415–420Google Scholar
  31. 31.
    Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC (2002) Light during darkness, melatonin suppression and cancer progression. Neuro Endocrinol Lett 23 (Suppl 2):52–56PubMedGoogle Scholar
  32. 32.
    Anisimov VN (2003) The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 46:221–234PubMedGoogle Scholar
  33. 33.
    Hansen J (2001) Light at night, shift work and breast cancer risk. Natl Cancer Inst 93:1513–1515Google Scholar
  34. 34.
    Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77CrossRefPubMedGoogle Scholar
  35. 35.
    Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562PubMedGoogle Scholar
  36. 36.
    Davis S, Mirick DK, Stevens RG (2002) Residential magnetic fields and the risk of breast cancer. Am J Epidemiol 155:446–454CrossRefPubMedGoogle Scholar
  37. 37.
    Swerdlow A (2003) Shift work and breast cancer: a critical review of the epidemiological evidence. [132], 1–28. Sudbury, Health and Safety Excecutive. Research reportGoogle Scholar
  38. 38.
    Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE (2004) Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 13:936–943PubMedGoogle Scholar
  39. 39.
    Travis RC, Allen DS, Fentiman IS, Key TJ (2004) Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 96:475–482PubMedGoogle Scholar
  40. 40.
    Hrushesky WJ, Blask DE (2004) Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 96:888–889PubMedGoogle Scholar
  41. 41.
    Andersen A, Barlow L, Engeland A, Kjærheim K, Lynge E, Pukkala E (1999) Work-related cancer in the Nordic countries. Scand J Work Environ Health 25(Suppl 2):1–116PubMedGoogle Scholar
  42. 42.
    Lie JA, Kjaerheim K (2003) Cancer risk among female nurses: a literature review. Eur J Cancer Prev 12:517–526PubMedGoogle Scholar
  43. 43.
    Lerchl A (1998) Flight attendants, breast cancer, and melatonin. Lancet 352:1388–1389CrossRefPubMedGoogle Scholar
  44. 44.
    Lynge E (2001) Cancer in the air. Int J Epidemiol 30:830–832CrossRefPubMedGoogle Scholar
  45. 45.
    Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12:95–101CrossRefPubMedGoogle Scholar
  46. 46.
    Kliukiene J, Tynes T, Andersen A (2003) Follow-up of radio and telegraph operators with exposure to electromagnetic fields and risk of breast cancer. Eur J Cancer Prev 12:301–307CrossRefPubMedGoogle Scholar
  47. 47.
    Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204CrossRefPubMedGoogle Scholar
  48. 48.
    Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E (2004) Cancer Risks among Radiologists and Radiologic Technologists: Review of Epidemiologic Studies. RadiologyGoogle Scholar
  49. 49.
    Hansen J, Meersohn A. Kræftsygelighed blandt danske lønmodtagere (1970–97) fordelt på Arbejdstilsynets 49 branchegrupper. 1–113. 2003. København, ArbejdstilsynetGoogle Scholar
  50. 50.
    Pukkala E, Auvinen A, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants, 1967- 92. BMJ 311:649–652PubMedGoogle Scholar
  51. 51.
    Rafnsson V, Gunnarsdóttir H, (1990) Mortality study of fertiliser manufacturers in Iceland. Br J Ind Med 47:721–725PubMedGoogle Scholar
  52. 52.
    Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204CrossRefPubMedGoogle Scholar
  53. 53.
    Schernhammer ES, Laden F, Speizer FE, etal. (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. Natl Cancer Inst 93:1563–1568Google Scholar
  54. 54.
    Schernhammer E, Schulmeister K (2004) Light at night and cancer risk. Photochem Photobiol 79:316–318CrossRefPubMedGoogle Scholar
  55. 55.
    Feychting M, Österlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494PubMedGoogle Scholar
  56. 56.
    Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84:397–399CrossRefPubMedGoogle Scholar
  57. 57.
    Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80:1459–1460CrossRefPubMedGoogle Scholar
  58. 58.
    Hahn RA, (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208–210PubMedGoogle Scholar
  59. 59.
    Kerenyi N (2002) Re: Night shift work, light at night, and risk of breast cancer. JNCI 94:531–532PubMedGoogle Scholar
  60. 60.
    Hansen J (2002) Night shift work, light at night, and risk of breast cancer: response. J Natl Cancer Inst 94:533–534Google Scholar
  61. 61.
    Erren TC (2002) Does light cause internal cancers? The problem and challenge of an ubiquitous exposure. Neuro Endocrinol Lett 23 Suppl 2:61–70PubMedGoogle Scholar
  62. 62.
    Stevens RG (2002) Lighting during the day and night: possible impact on risk of breast cancer. Neuro Endocrinol Lett 23 (Suppl 2):57–60PubMedGoogle Scholar
  63. 63.
    Frank L (2000) Epidemiology: when an entire country is a cohort. Science 287:2398–2399PubMedGoogle Scholar
  64. 64.
    Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry–history, content, quality and use. Dan Med Bull 44:535–539PubMedGoogle Scholar
  65. 65.
    Storm HH (1996) Cancer registries in epidemiologic research. Cancer Causes Control 7:299–301CrossRefPubMedGoogle Scholar
  66. 66.
    Olsen JH, Jensen OM (1987) Occupation and risk of cancer in Denmark.An analysis of 93810 cancer cases, 1970–79. Scand J Work Environ Health 13(Suppl. 1):1–91PubMedGoogle Scholar
  67. 67.
    Hansen J, Schneider T, Olsen JH, Laursen B (1993) Availability of data on humans potentially exposed to suspected carcinogens in the Danish working environment. Pharmacol Toxicol 72 (Suppl 1):77–85PubMedGoogle Scholar
  68. 68.
    Stahlberg C, Pedersen AT, Andersen ZJ, etal. (2004) Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy. Br J Cancer 91:644–650PubMedGoogle Scholar
  69. 69.
    Hundrup YA, Obel EB, Rasmussen NK, Gronbaek M (2004) [The Danish Nurse Cohort Study 1993–2003]. Ugeskr Laeger 166:1451–1454PubMedGoogle Scholar
  70. 70.
    Hundrup YA, Thoning H, Obel EB, Rasmussen NK, Philip J (2002) Lifestyle factors and choice of hormone replacement therapy among Danish nurses. Scand J Public Health 30:47–53CrossRefPubMedGoogle Scholar
  71. 71.
    Hansen J (2002) Risiko for kræft blandt danske sygeplejersker (1980–97). København 2002, Kræftens BekæmpelseGoogle Scholar
  72. 72.
    Winchester DJ (1996) Male breast cancer. Semin Surg Oncol 12:364–369PubMedGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  1. 1.Institute of Cancer Epidemiology, Danish Cancer SocietyCopenhagenDenmark

Personalised recommendations